The time is right to get into the blossoming field of stem cells, believes the high-profile founder of Neuronyx Inc. , Hubert Schoemaker, PhD. Fresh from the sale of Centocor Inc. , the first-generation biotech that he co-founded, to Johnson & Johnson [See Deal], Schoemaker founded Neuronyx in 1999 to develop stem cell-based therapies for neurological disorders.
A developing body of research gathered by academic centers and early stem-cell companies like Geron Corp. , Advanced Cell...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?